|
Older and younger chronic leukemia patients may need different therapy
Medical Xpress “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
 HealthNewsDigest.com |
Older and Younger Chronic Leukemia Patients May Need Different Therapy
HealthNewsDigest.com “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
Search in our News ChannelsPipelineReview.com (press release)The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II tr…
|
Celgene Int’l Sàrl Announces Results From Several Studies – Quick Facts
RTT News The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II trial analyzing the combination of lenalidomide and rituximab. |
Celgene (CELG) Updates on Multiple REVLIMID Trials in Treating NHLStreetInsider.com (subscription)The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidom…
Imprime PGG in Combination with Monoclonal Antibody Therapy Achieves 64 …PipelineReview.com (press release)EAGAN, MN, USA I December 10, 2012 I All subjects in a phase 1 study of high risk, chronic lymphocytic leukemia responded to the combination th…
Immunomedics Provides Clinical Updates on Subcutaneous Injections of …MarketWatch (press release)The complementarity-determining regions (CDRs) of veltuzumab are identical to rituximab, except for one amino acid residue, which appears to give veltuzu…
New Results add to Growing Body of Evidence That Support Bendamustine …PR Newswire UK (press release)Five sets of new data analyses presented this week at the 54th annual meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, show t…
HealioCombination of ibrutinib and rituximab shows promise against chronic …News-Medical.netA two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with min…
Roche announces positive studies of MabThera with subcutaneous injectionpharmabiz.comRoche has reported results from two studies which showed that a fixed dose of MabThera (rituximab) can be administered subcutaneously (SC), potentially allowing patien…